Arthur F. Ryan - Oct 1, 2024 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
Director
Signature
/s/**Arthur F. Ryan
Stock symbol
REGN
Transactions as of
Oct 1, 2024
Transactions value $
-$104,878
Form type
4
Date filed
10/3/2024, 04:02 PM
Previous filing
Sep 5, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Sale -$3.12K -3 -0.02% $1,041.35 17.7K Oct 1, 2024 Direct F1, F2
transaction REGN Common Stock Sale -$1.04K -1 -0.01% $1,042.31 17.7K Oct 1, 2024 Direct F1
transaction REGN Common Stock Sale -$5.22K -5 -0.03% $1,043.39 17.7K Oct 1, 2024 Direct F1, F3
transaction REGN Common Stock Sale -$9.4K -9 -0.05% $1,044.62 17.7K Oct 1, 2024 Direct F1, F4
transaction REGN Common Stock Sale -$7.32K -7 -0.04% $1,045.27 17.7K Oct 1, 2024 Direct F1, F5
transaction REGN Common Stock Sale -$9.42K -9 -0.05% $1,046.53 17.6K Oct 1, 2024 Direct F1, F6
transaction REGN Common Stock Sale -$12.6K -12 -0.07% $1,047.44 17.6K Oct 1, 2024 Direct F1, F7
transaction REGN Common Stock Sale -$12.6K -12 -0.07% $1,048.54 17.6K Oct 1, 2024 Direct F1, F8
transaction REGN Common Stock Sale -$9.45K -9 -0.05% $1,049.68 17.6K Oct 1, 2024 Direct F1, F9
transaction REGN Common Stock Sale -$6.3K -6 -0.03% $1,050.60 17.6K Oct 1, 2024 Direct F1, F10
transaction REGN Common Stock Sale -$9.46K -9 -0.05% $1,051.51 17.6K Oct 1, 2024 Direct F1, F11
transaction REGN Common Stock Sale -$4.21K -4 -0.02% $1,052.44 17.6K Oct 1, 2024 Direct F1, F12
transaction REGN Common Stock Sale -$4.21K -4 -0.02% $1,053.45 17.6K Oct 1, 2024 Direct F1, F13
transaction REGN Common Stock Sale -$3.16K -3 -0.02% $1,054.90 17.6K Oct 1, 2024 Direct F1, F14
transaction REGN Common Stock Sale -$3.17K -3 -0.02% $1,056.68 17.6K Oct 1, 2024 Direct F1, F15
transaction REGN Common Stock Sale -$2.11K -2 -0.01% $1,057.38 17.6K Oct 1, 2024 Direct F1, F16
transaction REGN Common Stock Sale -$2.12K -2 -0.01% $1,059.28 17.6K Oct 1, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Disposition/acquisition made pursuant to a plan intended to comply with Rule 10b5-1(c) adopted on August 7, 2023.
F2 Represents volume-weighted average price of sales of 3 shares of Company stock on October 1, 2024 at prices ranging from $1,041.10 to $1,041.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F3 Represents volume-weighted average price of sales of 5 shares of Company stock on October 1, 2024 at prices ranging from $1,043.12 to $1,043.75. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F4 Represents volume-weighted average price of sales of 9 shares of Company stock on October 1, 2024 at prices ranging from $1,044.14 to $1,044.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F5 Represents volume-weighted average price of sales of 7 shares of Company stock on October 1, 2024 at prices ranging from $1,045.00 to $1,045.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F6 Represents volume-weighted average price of sales of 9 shares of Company stock on October 1, 2024 at prices ranging from $1,046.14 to $1,046.87. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F7 Represents volume-weighted average price of sales of 12 shares of Company stock on October 1, 2024 at prices ranging from $1,047.09 to $1,047.90. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F8 Represents volume-weighted average price of sales of 12 shares of Company stock on October 1, 2024 at prices ranging from $1,048.00 to $1,048.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F9 Represents volume-weighted average price of sales of 9 shares of Company stock on October 1, 2024 at prices ranging from $1,049.18 to $1,049.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F10 Represents volume-weighted average price of sales of 6 shares of Company stock on October 1, 2024 at prices ranging from $1,050.27 to $1,050.93. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F11 Represents volume-weighted average price of sales of 9 shares of Company stock on October 1, 2024 at prices ranging from $1,051.10 to $1,051.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F12 Represents volume-weighted average price of sales of 4 shares of Company stock on October 1, 2024 at prices ranging from $1,052.37 to $1,052.65. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F13 Represents volume-weighted average price of sales of 4 shares of Company stock on October 1, 2024 at prices ranging from $1,053.06 to $1,053.77. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F14 Represents volume-weighted average price of sales of 3 shares of Company stock on October 1, 2024 at prices ranging from $1,054.76 to $1,054.97. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F15 Represents volume-weighted average price of sales of 3 shares of Company stock on October 1, 2024 at prices ranging from $1,056.55 to $1,056.95. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.
F16 Represents volume-weighted average price of sales of 2 shares of Company stock on October 1, 2024 at prices ranging from $1,057.28 to $1,057.48. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on October 1, 2024 at each separate price.